Corcept Therapeutics, Inc. (CORT)
32.19
+0.04
(+0.12%)
USD |
NASDAQ |
Mar 16, 16:00
32.19
0.00 (0.00%)
After-Hours: 18:24
Corcept Therapeutics EPS Diluted (Quarterly) : 0.1994 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -0.5641 |
| Alphatec Holdings, Inc. | -0.1428 |
| Harrow, Inc. | 0.178 |
| Ultragenyx Pharmaceutical, Inc. | -1.291 |
| Amneal Pharmaceuticals, Inc. | 0.1069 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 23.90M |
| Revenue (Quarterly) | 202.12M |
| Total Expenses (Quarterly) | 178.22M |
| Enterprise Value | 3.054B |
| Gross Profit Margin (Quarterly) | 98.74% |
| Profit Margin (Quarterly) | 11.83% |
| Earnings Yield | 2.54% |
| Operating Earnings Yield | 1.16% |
| Normalized Earnings Yield | 2.541 |